TRT still feels off? What the science says about suboptimal response

What did @trtover40 actually say?

The creator listed five signs that your TRT dose might be too low: poor recovery from training, libido that lifted briefly then returned to baseline, no change in confidence, lack of internal motivation, and a general sense that "I expected a bigger change than this." These are framed as patterns, not prescriptions, and the creator was upfront that this is not medical advice.

To be clear, the video is not claiming TRT cures anything. It is describing subjective response markers that patients on testosterone replacement therapy sometimes report when their serum levels are not optimized. That framing matters, and it is worth keeping in mind as we work through the evidence.

Does the science back this up?

Mostly, yes. The symptom clusters described here are consistent with what shows up in peer-reviewed literature on hypogonadism and TRT response. But the relationship between dose and symptom relief is messier than the video implies.

A 2006 study by Bhasin et al. in the Journal of Clinical Endocrinology and Metabolism established that testosterone has dose-dependent effects on muscle mass, strength, and body composition, which connects directly to the recovery point. On libido, a 2016 meta-analysis by Corona et al. in Sexual Medicine Reviews confirmed that testosterone therapy improves sexual desire in hypogonadal men, but noted that response varies considerably and does not scale linearly with dose. The confidence and motivation claims are harder to pin down. Research by Zarrouf et al. (2009, Journal of Psychiatric Practice) found testosterone supplementation improved mood and depressive symptoms, but effect sizes were modest and individual variation was high.

The early libido lift followed by return to baseline is a documented clinical observation, but it is not always a dosing problem. It can also reflect estradiol imbalance, SHBG levels, or simple expectation effects.

What did they get wrong (or right)?

The creator gets credit for intellectual honesty. Framing these as "patterns I keep seeing" rather than clinical diagnoses is appropriate. The five markers selected are genuinely the ones clinicians use in symptom-based TRT monitoring, loosely aligned with validated tools like the Aging Males' Symptoms scale.

Where the video falls short is in the implicit assumption that these symptoms point specifically to an underdose problem. That is an oversimplification. Poor recovery could reflect sleep, nutrition, or overtraining. Flat libido after an initial lift is as likely to signal elevated estradiol or high SHBG as it is to signal insufficient testosterone. A 2011 study by Ramasamy et al. in BJU International found that some men on TRT with adequate serum testosterone still reported poor symptomatic response, suggesting dose is only one variable.

The confidence and motivation section is the weakest. Attributing those to TRT underdosing without ruling out depression, thyroid dysfunction, or life circumstances is a stretch. The creator does not make that error explicitly, but the framing nudges viewers toward dose as the answer.

What should you actually know?

Symptom-based monitoring is legitimate and underused in TRT management. Serum testosterone levels alone are a poor proxy for how a patient feels. Several clinical guidelines, including guidance from the Endocrine Society, recommend combining lab values with patient-reported outcomes to guide dosing decisions.

But symptoms are not a direct dial on dose. If you are on TRT and still feel off, a useful checklist before assuming underdose includes: Where is your estradiol? What is your SHBG? Are you sleeping? What does your hematocrit look like? Is your thyroid function normal? These are questions for a prescribing clinician, not a TikTok comment section.

The creator's final point, that the feeling of "I expected a bigger change than this" matters, is actually well-taken. Unmet expectations in TRT are clinically meaningful and can reflect genuine subtherapeutic dosing. A 2021 review by Khera in Urologic Clinics of North America noted that patient satisfaction with TRT is strongly influenced by pre-treatment expectations being addressed upfront.